These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5380907)

  • 21. Effect of clofibrate and 1-methyl-4-piperidyl bis (p-chlorophenoxy) acetate (Sandox 42-348) on steroid and drug metabolism by rat liver microsomes.
    Salvador RA; Haber S; Atkins C; Gommi BW; Welch RM
    Life Sci; 1970 Apr; 9(7):397-407. PubMed ID: 5445848
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum phospholipid alterations and their control by chlorophenoxyisobutyrate and betabenzalbutyrate in puromycin aminonucleoside induced nephrotic syndrome in the rat.
    Gallt C; Edwards KD; Paoletti R
    Life Sci II; 1970 May; 9(9):523-34. PubMed ID: 5452796
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of ethyl p-chlorophenoxyisobutyrate on rat adipose lipoprotein lipase activity.
    Tolman EL; Tepperman HM; Tepperman J
    Am J Physiol; 1970 May; 218(5):1313-8. PubMed ID: 4314568
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical trial of methyl clofenapate (a derivative of clofibrate) in patients with essential hyperlipidaemias--with special reference to type II (primary) hyperlipidaemia.
    Craig GM; Walton KW
    Atherosclerosis; 1972; 15(2):189-98. PubMed ID: 4579956
    [No Abstract]   [Full Text] [Related]  

  • 25. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of clofibrate and high fat diets on adrenaline-induced lipolysis in isolated rat adipose tissue.
    Kokatnur MG; Blackard WG
    J Atheroscler Res; 1969; 10(3):319-25. PubMed ID: 5364083
    [No Abstract]   [Full Text] [Related]  

  • 27. Clofibrate, fibrinolysis, and platelet stickiness.
    Fearnley GR
    Br Med J; 1970 Oct; 4(5727):114. PubMed ID: 5471757
    [No Abstract]   [Full Text] [Related]  

  • 28. Rat hepatocyte peroxisomes: ultrastructural alterations following cessation of chronic dietary clofibrate administration.
    Hartman HA; Tousimis AJ
    Experientia; 1969 Dec; 25(12):1248-9. PubMed ID: 5365841
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of atromid-S and high fat diet on lipid contents and lipolysis in rat tissues and serum.
    Grafnetter D; Mrhová O; Janda J
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):159-73. PubMed ID: 5551199
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of short-term use of clofibrate on the blood level of cholesterol, beta lipoproteins and free fatty acids].
    Modzelewski A; Zaczek-Modzelewska T
    Wiad Lek; 1970 Nov; 23(21):1937-9. PubMed ID: 5485649
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term therapy of adult cases of primary hypertriglyceridaemia with clofibrate (ethyl-p-chlorophenoxyisobutyrate).
    Braunsteiner H; Herbst M; Sandhofer F; Sailer S
    Ger Med Mon; 1968 Feb; 13(2):65-72. PubMed ID: 5653144
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacokinetics of clofibrate in uremic patients treated with dialysis. Effects of dietetic and drug therapy on triglycerides in the blood].
    Garini G; Vaona GL; Arisi L; Bignardi L; David S; Gaudiano V; Rossi E; Savazzi GM; Cambi V; Migone L
    Minerva Nefrol; 1979; 26(1):55-60. PubMed ID: 471323
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of clofibrate on acetyl-CoA carboxylase activity in hepatocytes.
    Harkins JB; Yates RD
    Z Zellforsch Mikrosk Anat; 1971; 119(3):321-5. PubMed ID: 5569050
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of hypertriglyceridemia with tibric acid and clofibrate. Cross-over studies, effects on lipoproteins and absence of post-drug rebound.
    Smith FR; Noble RP; Goodman DS
    Atherosclerosis; 1978 Mar; 29(3):345-54. PubMed ID: 666884
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of essential hyperlipemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fibrinolytic action of aluminum bis-alpha-para-chlorophenoxy isobutyrate].
    Daver J; Ripoll S; Du Pasquier JP; Edmond E; Palus JC; Ricoeur M; Aubert D
    Therapie; 1969; 24(3):419-28. PubMed ID: 5399537
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of clofibrate administration on the urinary vanilmandelic acid method of Pisano et al.
    Sacre MH; Walker G
    Clin Chim Acta; 1970 Oct; 30(1):215-7. PubMed ID: 5473568
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of clofibrate treatment on arginine-induced insulin secretion in endogenous hypertriglyceridemia.
    Fedele D; Tiengo A; Muggeo M; Nosadini R; Crepaldi G
    Atherosclerosis; 1976; 25(2-3):191-8. PubMed ID: 1008908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethanol metabolism in rats treated with ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate).
    Kähönen MT; Ylikahri RH; Hassinen I
    Life Sci II; 1971 Jun; 10(12):661-70. PubMed ID: 5560535
    [No Abstract]   [Full Text] [Related]  

  • 40. Regulation of hepatic cholesterol biosynthesis by clofibrate administration.
    White LW
    J Pharmacol Exp Ther; 1971 Aug; 178(2):361-70. PubMed ID: 5570460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.